{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:54:55Z","timestamp":1791327295392,"version":"4.3.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.critrevonc.2020.102944","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T12:32:37Z","timestamp":1584707557000},"page":"102944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Comparative efficacy of 20 graft-versus-host disease prophylaxis therapies for patients after hematopoietic stem-cell transplantation: A multiple-treatments network meta-analysis"],"prefix":"10.1016","volume":"150","author":[{"given":"Xin","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1613-4877","authenticated-orcid":false,"given":"Jiaqian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengsen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7560-7195","authenticated-orcid":false,"given":"Yue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.critrevonc.2020.102944_bib0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2009-03-212290","article-title":"Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network","volume":"114","author":"Alousi","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2020.102944_bib0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/bjh.13931","article-title":"The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial","volume":"173","author":"Armand","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.critrevonc.2020.102944_bib0015","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.3324\/haematol.2017.171157","article-title":"Steroid treatment of acute graft-versus-host disease grade I: a randomized trial","volume":"102","author":"Bacigalupo","year":"2017","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.critrevonc.2020.102944_bib0020","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3109\/10428194.2011.634039","article-title":"Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant","volume":"53","author":"Bashir","year":"2012","journal-title":"Leuk. Lymphoma"},{"issue":"3","key":"10.1016\/j.critrevonc.2020.102944_bib0025","first-page":"273","article-title":"Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis","volume":"12","author":"Bass","year":"1993","journal-title":"Bone Marrow Transplant."},{"issue":"9","key":"10.1016\/j.critrevonc.2020.102944_bib0030","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1182\/blood-2006-04-017780","article-title":"Phase 1\/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)","volume":"108","author":"Blazar","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2020.102944_bib0035","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1016\/S2352-3026(18)30221-7","volume":"6","author":"Bolanos-Meade","year":"2019","journal-title":"Lancet Haematol."},{"issue":"24","key":"10.1016\/j.critrevonc.2020.102944_bib0040","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1182\/blood-2009-04-214437","article-title":"ATG-induced expression of FOXP3 in human CD4(+) T cells in vitro is associated with T-cell activation and not the induction of FOXP3(+) T regulatory cells","volume":"114","author":"Broady","year":"2009","journal-title":"Blood"},{"issue":"1\u20133","key":"10.1016\/j.critrevonc.2020.102944_bib0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.schres.2009.07.012","article-title":"Schizophrenia and breast cancer incidence: a systematic review of clinical studies","volume":"114","author":"Bushe","year":"2009","journal-title":"Schizophr. Res."},{"issue":"15","key":"10.1016\/j.critrevonc.2020.102944_bib0050","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/cncr.30540","article-title":"Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: long-term outcomes of a prospective randomized trial","volume":"123","author":"Chang","year":"2017","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2020.102944_bib0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1017\/S1121189X00004577","article-title":"What is a risk ratio?","volume":"16","author":"Cipriani","year":"2007","journal-title":"Epidemiol. Psichiatr. Soc."},{"issue":"1","key":"10.1016\/j.critrevonc.2020.102944_bib0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-139-1-200307010-00007","article-title":"Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial","volume":"139","author":"Cordonnier","year":"2003","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"10.1016\/j.critrevonc.2020.102944_bib0065","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bbmt.2009.08.003","article-title":"A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease","volume":"15","author":"Couriel","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"8","key":"10.1016\/j.critrevonc.2020.102944_bib0070","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1182\/blood-2014-04-567164","article-title":"Tacrolimus\/sirolimus vs tacrolimus\/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT","volume":"124","author":"Cutler","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2020.102944_bib0075","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1182\/blood.V96.3.1194a","article-title":"Cyclosporine (CSP)or CSP plus methylprednisolone for graft-versus-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial","volume":"96","author":"Deeg","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2020.102944_bib0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"issue":"1","key":"10.1016\/j.critrevonc.2020.102944_bib0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2141.2012.09129.x","article-title":"Diagnosis and management of acute graft-versus-host disease","volume":"158","author":"Dignan","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2020.102944_bib0090","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3324\/haematol.2017.183434","article-title":"Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: low incidence of lower gastrointestinal tract disease","volume":"103","author":"Drobyski","year":"2018","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.critrevonc.2020.102944_bib0095","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1182\/blood-2008-01-130146","article-title":"Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro","volume":"111","author":"Feng","year":"2008","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.critrevonc.2020.102944_bib0100","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1470-2045(09)70225-6","article-title":"Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial","volume":"10","author":"Finke","year":"2009","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2020.102944_bib0105","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.bbmt.2007.06.012","article-title":"A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation","volume":"13","author":"Fong","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2020.102944_bib0110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.critrevonc.2018.11.001","article-title":"Retuning the immune system in myelodysplastic syndromes: from immunomodulatory approaches to vaccination strategies and non myeloablative hemopoietic cell transplant","volume":"133","author":"Fozza","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2020.102944_bib0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.leukres.2017.02.006","article-title":"Low incidence of acute graft-versus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantation","volume":"57","author":"Gao","year":"2017","journal-title":"Leuk. Res."},{"key":"10.1016\/j.critrevonc.2020.102944_bib0120","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25717","article-title":"Clinical characteristics and cytokine biomarkers in patients with chronic graft-versus-Host disease persisting seven or more years after diagnosis","author":"Goklemez","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2020.102944_bib0125","first-page":"499","article-title":"Immune globulin therapy in allogeneic bone marrow transplant: a critical review","volume":"13","author":"Guglielmo","year":"1994","journal-title":"Bone Marrow Transplant."},{"issue":"7132","key":"10.1016\/j.critrevonc.2020.102944_bib0130","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/bmj.316.7132.690","article-title":"Interpreting treatment effects in randomised trials","volume":"316","author":"Guyatt","year":"1998","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.critrevonc.2020.102944_bib0135","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1038\/bmt.2013.89","article-title":"Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation","volume":"48","author":"Hamilton","year":"2013","journal-title":"Bone Marrow Transplant."},{"issue":"7414","key":"10.1016\/j.critrevonc.2020.102944_bib0140","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.critrevonc.2020.102944_bib0145","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.bmt.1705955","article-title":"Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants","volume":"41","author":"Hoyt","year":"2008","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.critrevonc.2020.102944_bib0150","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3324\/haematol.2013.088781","article-title":"Quality of life associated with sirolimus for prevention of graft-versus-host disease: results from a randomized trial","volume":"99","author":"Jim","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.critrevonc.2020.102944_bib0155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/bmt.2015.222","article-title":"A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation","volume":"51","author":"Kanda","year":"2016","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"10.1016\/j.critrevonc.2020.102944_bib0160","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/bmt.2017.63","article-title":"Predictors of overall survival among patients treated with sirolimus\/tacrolimus vs methotrexate\/tacrolimus for GvHD prevention","volume":"52","author":"Khimani","year":"2017","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.critrevonc.2020.102944_bib0165","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3324\/haematol.2017.176859","article-title":"Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results","volume":"103","author":"Koreth","year":"2018","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.critrevonc.2020.102944_bib0170","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3324\/haematol.2014.108340","article-title":"A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation","volume":"99","author":"Kornblit","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.critrevonc.2020.102944_bib0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1506002","article-title":"Antilymphocyte globulin for prevention of chronic graft-versus-Host disease","volume":"374","author":"Kroger","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2020.102944_bib0180","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/968213","article-title":"Multipotent mesenchymal stromal cells for the prophylaxis of acute graft-versus-Host Disease-A phase II study","volume":"2012","author":"Kuzmina","year":"2012","journal-title":"Stem Cells Int."},{"issue":"5","key":"10.1016\/j.critrevonc.2020.102944_bib0185","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1182\/blood-2004-03-0854","article-title":"Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial","volume":"104","author":"Lee","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.critrevonc.2020.102944_bib0190","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.bbmt.2008.06.013","article-title":"Long-term follow-up of a phase I\/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT)","volume":"14","author":"Levine","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"8","key":"10.1016\/j.critrevonc.2020.102944_bib0195","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S1470-2045(17)30417-5","article-title":"Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial","volume":"18","author":"Locatelli","year":"2017","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2020.102944_bib0200","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1681\/ASN.2006050422","article-title":"A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells","volume":"17","author":"Lopez","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"16","key":"10.1016\/j.critrevonc.2020.102944_bib0205","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1182\/blood-2009-11-251595","article-title":"High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease","volume":"115","author":"Luznik","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2020.102944_bib0210","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.bbmt.2014.12.025","article-title":"Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial","volume":"21","author":"Maziarz","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"26","key":"10.1016\/j.critrevonc.2020.102944_bib0215","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1182\/blood-2016-01-694349","article-title":"Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome","volume":"127","author":"Michel","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.critrevonc.2020.102944_bib0220","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","article-title":"Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond","volume":"21","author":"Mohty","year":"2007","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.critrevonc.2020.102944_bib0225","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2007.06.027","article-title":"Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs","volume":"63","author":"Nemeroff","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.critrevonc.2020.102944_bib0230","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1182\/blood-2014-12-617019","article-title":"Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment","volume":"127","author":"Orozco","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2020.102944_bib0235","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1200\/JCO.2010.30.6357","article-title":"Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I\/II controlled, adaptively randomized study","volume":"29","author":"Parmar","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2020.102944_bib0240","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbmt.2010.01.010","article-title":"A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft-versus-host disease prophylaxis","volume":"16","author":"Perkins","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"7","key":"10.1016\/j.critrevonc.2020.102944_bib0245","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3324\/haematol.2015.123588","article-title":"Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease","volume":"100","author":"Pidala","year":"2015","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.critrevonc.2020.102944_bib0250","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3324\/haematol.2017.171199","article-title":"In vivo IL-12\/IL-23p40 neutralization blocks Th1\/Th17 response after allogeneic hematopoietic cell transplantation","volume":"103","author":"Pidala","year":"2018","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.critrevonc.2020.102944_bib0255","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1182\/blood-2013-10-534297","article-title":"The addition of sirolimus to tacrolimus\/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children\u2019s Oncology Group\/Pediatric Blood and Marrow Transplant Consortium trial","volume":"123","author":"Pulsipher","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2020.102944_bib0260","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1182\/blood-2007-08-106526","article-title":"Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivo","volume":"111","author":"Ruzek","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2020.102944_bib0265","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0962280207080643","article-title":"Evaluation of networks of randomized trials","volume":"17","author":"Salanti","year":"2008","journal-title":"Stat. Methods Med. Res."},{"issue":"23","key":"10.1016\/j.critrevonc.2020.102944_bib0270","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1182\/blood-2011-01-329821","article-title":"Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius","volume":"117","author":"Socie","year":"2011","journal-title":"Blood"},{"issue":"36","key":"10.1016\/j.critrevonc.2020.102944_bib0275","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1200\/JCO.2017.75.8177","article-title":"Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation","volume":"35","author":"Soiffer","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"7280","key":"10.1016\/j.critrevonc.2020.102944_bib0280","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/bmj.322.7280.226","article-title":"Sifting the evidence-what\u2019s wrong with significance tests?","volume":"322","author":"Sterne","year":"2001","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.critrevonc.2020.102944_bib0285","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM198603203141201","article-title":"Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia","volume":"314","author":"Storb","year":"1986","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2020.102944_bib0290","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJM199009133231103","article-title":"Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation","volume":"323","author":"Sullivan","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.critrevonc.2020.102944_bib0295","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3324\/haematol.2016.149294","article-title":"A prospective randomized trial comparing cyclosporine\/methotrexate and tacrolimus\/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation","volume":"101","author":"Torlen","year":"2016","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.critrevonc.2020.102944_bib0300","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1704594","article-title":"Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes","volume":"34","author":"Uberti","year":"2004","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"10.1016\/j.critrevonc.2020.102944_bib0305","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.bbmt.2007.08.049","volume":"13","author":"van Burik","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"14","key":"10.1016\/j.critrevonc.2020.102944_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11140","article-title":"A systematic review and economic evaluation of statins for the prevention of coronary events","volume":"11","author":"Ward","year":"2007","journal-title":"Health Technol. Assess."},{"issue":"10","key":"10.1016\/j.critrevonc.2020.102944_bib0315","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.bbmt.2015.05.018","article-title":"Cannabidiol for the prevention of graft-versus-Host-Disease after allogeneic hematopoietic cell transplantation: results of a phase II study","volume":"21","author":"Yeshurun","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2020.102944_bib0320","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.critrevonc.2018.05.017","article-title":"Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis","volume":"133","author":"Yu","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2020.102944_bib0325","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2007-06-094482","article-title":"Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells","volume":"111","author":"Zeiser","year":"2008","journal-title":"Blood"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842820300822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842820300822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:32:04Z","timestamp":1760902324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842820300822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":65,"alternative-id":["S1040842820300822"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102944","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy of 20 graft-versus-host disease prophylaxis therapies for patients after hematopoietic stem-cell transplantation: A multiple-treatments network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102944"}}